Sorry, you need to enable JavaScript to visit this website.
Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Helpful Information for Canadian Consumers

To report an adverse event (or suspected side-effect) experienced with a Pfizer medication (prescription, no-prescription or a vaccine) please contact us at 1-866-723-7111 or by fax at 1 855 242-5652. Reports can be made directly to Health Canada as well through the Canada Vigilance Program at 1 866 234-2345.

For all information related to our products, please consult the patient information brochure and the Product Monograph, which are available at Kindly note that we are unable to provide medical advice, and any questions related to your medical condition should be directed to your physician or pharmacist.

Do you need information about a Pfizer over the counter product, such as Centrum or Advil?
Call: Pfizer Consumer Healthcare at (888) 275-9938

Do you need information about ELIQUIS?
Call: Bristol-Myers Squibb Canada at (866) 463-6267

Do you need information about ENBREL?
Call: Amgen at (866) 502-6436

Do you need information about SPIRIVA?
Call: Boehringer Ingelheim at (800) 263-5103 ext. 84633

Do you need information about EPIPEN?
Call: Epipen Info Line (877) 374-7361 or visit

Do you need information about other Pfizer Prescription products?
Call: Pfizer Medical Information at (800) 463-6001

Find Health and Wellness Information
Please visit our health & well-being website devoted to help you learn simple ways to manage and lead a healthier life at:

Find Support
Find a local support group in a variety of areas from diseases and conditions to health and wellness. This unique Canadian directory provides contact information for over 10,000 national, provincial and local non-profit organizations. Click here.